Ryan K Schmocker - JoVE Visualize

Showing results (21-30 of 27) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 27 results.

Annals of Surgical Oncology|October 14, 2020

An Aggressive Approach to Locally Confined Pancreatic Cancer: Defining Surgical and Oncologic Outcomes Unique to Pancreatectomy with Celiac Axis Resection (DP-CAR)Ryan K Schmocker, Michael J Wright, Ding Ding, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 17, 2020

Perioperative Outcomes of Robotic Pancreaticoduodenectomy: a Propensity-Matched Analysis to Open and Laparoscopic PancreaticoduodenectomyA Floortje van Oosten, Ding Ding, Joseph R Habib, et al.

Annals of Surgical Oncology|February 3, 2024

Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC CollaborativeNadege T Fackche, Ryan K Schmocker, Richard Nudotor, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 26, 2021

The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC CollaborativeNadege Fackche, Ryan K Schmocker, Boateng Kubi, et al.

Hepatobiliary Surgery and Nutrition|June 11, 2026

Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?-a systematic review and meta-analysisSandro Hügli, Victor Lopez-Lopez, Sarvar Abdurakhmonov, et al.

Annals of Surgical Oncology|April 5, 2023

FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic ReviewDilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F Palm, et al.

Journal of the National Cancer Institute|July 13, 2026

Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysisVictor Lopez-Lopez, Tanja Hasse, Philipp Houben, et al.

Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 27 results.

Annals of Surgical Oncology|October 14, 2020

An Aggressive Approach to Locally Confined Pancreatic Cancer: Defining Surgical and Oncologic Outcomes Unique to Pancreatectomy with Celiac Axis Resection (DP-CAR)Ryan K Schmocker, Michael J Wright, Ding Ding, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 17, 2020

Perioperative Outcomes of Robotic Pancreaticoduodenectomy: a Propensity-Matched Analysis to Open and Laparoscopic PancreaticoduodenectomyA Floortje van Oosten, Ding Ding, Joseph R Habib, et al.

Annals of Surgical Oncology|February 3, 2024

Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC CollaborativeNadege T Fackche, Ryan K Schmocker, Richard Nudotor, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 26, 2021

The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC CollaborativeNadege Fackche, Ryan K Schmocker, Boateng Kubi, et al.

Hepatobiliary Surgery and Nutrition|June 11, 2026

Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?-a systematic review and meta-analysisSandro Hügli, Victor Lopez-Lopez, Sarvar Abdurakhmonov, et al.

Annals of Surgical Oncology|April 5, 2023

FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic ReviewDilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F Palm, et al.

Journal of the National Cancer Institute|July 13, 2026

Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysisVictor Lopez-Lopez, Tanja Hasse, Philipp Houben, et al.

Pageof 3